<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="hep41480-tbl-0003" xml:lang="en" orientation="portrait" position="float">
 <label>Table 3</label>
 <caption>
  <p>Indications for Treatment of Chronic HBV Infection</p>
 </caption>
 <table frame="hsides" rules="groups">
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <thead valign="top">
   <tr style="border-bottom:solid 1px #000000">
    <th align="left" colspan="5" valign="top" rowspan="1">Indications to Initiate Treatment</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" rowspan="8" colspan="1">AASLD</td>
    <td align="left" rowspan="1" colspan="1">
     <bold>Treat</bold>
    </td>
    <td align="left" colspan="2" rowspan="1">
     <bold>Potentially Treat</bold>
     <xref ref-type="fn" rid="hep41480-note-0010">*</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">
     <bold>Do Not Treat</bold>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">HBeAg‐positive</td>
    <td align="left" colspan="2" rowspan="1">HBeAg‐positive</td>
    <td align="left" rowspan="1" colspan="1">HBeAg‐positive</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">ALT elevated but &lt;2× ULN and HBV DNA &gt; 20,000 IU/mL</td>
    <td align="left" colspan="2" rowspan="1">ALT elevated &lt;2× ULN and HBV DNA ≥ 2,000 IU/mL persistent &gt;6 months</td>
    <td align="left" rowspan="1" colspan="1">ALT normal and HBV DNA &gt; 20,000 IU/mL</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Or</td>
    <td align="left" colspan="2" rowspan="1">ALT elevated ≥ 2× ULN and HBV DNA 2,000 to 20,000 IU/mL persistent &gt;6 months</td>
    <td align="left" rowspan="1" colspan="1">Or</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">HBeAg‐negative</td>
    <td align="left" colspan="2" rowspan="1">Or</td>
    <td align="left" rowspan="1" colspan="1">HBeAg‐negative</td>
   </tr>
   <tr>
    <td align="left" rowspan="3" colspan="1">ALT ≥ 2× ULN and HBV DNA &gt; 2,000 IU/mL</td>
    <td align="left" colspan="2" rowspan="1">HBeAg‐negative</td>
    <td align="left" rowspan="3" colspan="1">ALT normal and HBV DNA &lt; 2,000 IU/mL</td>
   </tr>
   <tr>
    <td align="left" colspan="2" rowspan="1">ALT normal but HBV DNA ≥ 2,000</td>
   </tr>
   <tr>
    <td align="left" colspan="2" rowspan="1">ALT elevated and HBV DNA ≥ 2,000</td>
   </tr>
   <tr>
    <td align="left" rowspan="5" colspan="1">EASL</td>
    <td align="left" rowspan="1" colspan="1">
     <bold>Should be treated</bold>
    </td>
    <td align="left" rowspan="1" colspan="1">
     <bold>May be treated</bold>
    </td>
    <td align="left" rowspan="1" colspan="1">
     <bold>Can be treated</bold>
    </td>
    <td align="left" rowspan="1" colspan="1">
     <bold>Do not treat</bold>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">HBeAg‐positive or HBeAg‐negative</td>
    <td align="left" rowspan="4" colspan="1">HBeAg‐positive chronic HBV infection and age &gt;30 years, regardless of severity of liver histological lesions</td>
    <td align="left" rowspan="2" colspan="1">HBeAg‐positive or negative</td>
    <td align="left" rowspan="4" colspan="1">Undetectable HBV DNA, normal ALT, and mild or no liver necroinflammation and fibrosis</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Chronic HBV infection
     <xref ref-type="fn" rid="hep41480-note-0011">†</xref>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Cirrhosis with/without decompensated and any detectable HBV DNA, regardless of ALT</td>
    <td align="left" rowspan="2" colspan="1">Chronic HBV infection and family history of HCC or cirrhosis and extrahepatic manifestations</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">HBV DNA &gt; 20,000 IU/mL and ALT &gt; 2× ULN, regardless of degree of fibrosis</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot id="hep41480-ntgp-0004">
  <title>Note</title>
  <fn id="hep41480-note-0009">
   <p>ALT upper limit of normal is defined as 35 U/L for males and 25 U/L for females.</p>
  </fn>
  <fn id="hep41480-note-0010">
   <label>*</label>
   <p>If staging indicates fibrosis ≥ F2 or activity ≥ A3, then treat regardless of HBV DNA or ALT, unless ALT normal and HBV DNA &lt; 2,000 IU/mL.</p>
  </fn>
  <fn id="hep41480-note-0011">
   <label>
    <sup>†</sup>
   </label>
   <p>HBV &gt; 2,000 IU/mL, ALT elevated, with at least moderate liver necroinflammation or fibrosis.</p>
  </fn>
  <fn id="hep41480-note-0012">
   <p>Abbreviations: ALT, alanine aminotransferase; CHB, chronic hepatitis B; ULN, upper limit of normal.</p>
  </fn>
 </table-wrap-foot>
 <permissions>
  <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
 </permissions>
</table-wrap>
